Polymerase Chain Reaction (PCR) Market 2024 : Industry Analysis, Trends, Segmentation, Regional Overview And Forecast 2033

Overview and Scope
Polymerase chain reaction (PCR) is a laboratory technique used to amplify specific segments of DNA. It involves repeated cycles of heating and cooling to denature, anneal, and extend DNA strands, resulting in the exponential amplification of the target sequence.

Sizing and Forecast
The polymerase chain reaction (PCR) market size has grown rapidly in recent years. It will grow from $10.33 billion in 2023 to $11.42 billion in 2024 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to rising number of research facilities, increasing number of patients for chronic and infectious diseases, increasing prevalence of genetic and chronic disorders, increasing population, and growing geriatric population.

The polymerase chain reaction (PCR) market size is expected to see rapid growth in the next few years. It will grow to $17.17 billion in 2028 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to the rising concerns over food safety, the increasing demand for safe and high-quality food products, the rising demand for molecular diagnostics, demand for personalized medicine, focus on digital polymerase chain reaction (dPCR). Major trends in the forecast period include real-time polymerase chain reaction, DNA sequencing technologies, diagnostic testing advancements, next-generation sequencing (NGS), microfluidics, lab-on-a-chip platforms, and advanced molecular diagnostic solutions development.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/polymerase-chain-reaction-pcr-global-market-report

The polymerase chain reaction (PCR) market covered in this report is segmented –

1) By Type: Conventional Polymerase Chain Reaction, Other Types
2) By Indication: Infectious Diseases, Oncology, Genetic Disorders, Other Indications
3) By Application: Medical, Non-Medical
4) By End User: Hospitals And Clinics, Pharmaceutical And Biotechnology Industries, Diagnostic Centers, Academic And Research Organization

North America was the largest region in the polymerase chain reaction (PCR) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction (PCR) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15638&type=smp

Major Driver Impacting Market Growth
The rising demand for personalized medicine is expected to fuel the growth of the polymerase chain reaction (PCR) market going forward. Personalized medicine, also known as precision medicine, refers to a medical approach that tailors healthcare decisions, practices, interventions, and treatments to individual characteristics of each patient. The demand for personalized medicine is increasing due to advancements in data analytics, patient-specific treatment responses, and the ability to tailor therapies based on individual genetic profiles. Polymerase Chain Reaction (PCR) helps personalized medicine by enabling the amplification and analysis of specific genetic sequences, allowing clinicians to tailor treatment plans based on individual genetic profiles. For instance, according to Personalized Medicine Coalition, a US-based professional membership organization, in 2022, approving 12 new personalized medicines represented approximately 34% of all newly approved therapies, indicating a substantial increase from previous years. Therefore, the rising demand for personalized medicine is driving the growth of the polymerase chain reaction market.

Key Industry Players
Major companies operating in the polymerase chain reaction (PCR) market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers GmbH, Becton, Dickinson and Company, GE HealthCare Technologies Inc, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc, Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc., 23andMe Holding Co., Ambry Genetics Corporation, Biocartis SA, Centogene N.V., Veritas Genetics

The polymerase chain reaction (pcr) market report table of contents includes:

1. Executive Summary

2. Polymerase Chain Reaction (PCR) Market Characteristics

3. Polymerase Chain Reaction (PCR) Market Trends And Strategies

4. Polymerase Chain Reaction (PCR) Market — Macro Economic Scenario

5. Global Polymerase Chain Reaction (PCR) Market Size and Growth
……..

32. Global Polymerase Chain Reaction (PCR) Market Competitive Benchmarking

33. Global Polymerase Chain Reaction (PCR) Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Polymerase Chain Reaction (PCR) Market

35. Polymerase Chain Reaction (PCR) Market Future Outlook and Potential Analysis

36. Appendix

https://goodprnews.com/bioelectric-medicine-market-players/